Stephen Hom, Gerard Rivera and their mentor Michael Hogue at an independent pharmacy early in their careers—where a shared commitment to patient affordability began.

In pharmacy school, you learn everything about how drugs work — and almost nothing about how to help patients afford them.

That lesson comes later when you’re in the field, making tough calls – literally and figuratively – to inform patients of how high their copay is for a newly prescribed medication.

Never an easy choice.

When I started working with Gerard at his independent pharmacy, we were big on finding patient assistance support for every patient by any means necessary.
We didn’t have any fancy tools, just a belief that affordability shouldn’t decide who gets well.

Because we’ve seen what happens when a patient gets to the counter, sees a copay they can’t afford, and walks away.

But we’ve also seen the other side — when a manufacturer invests a billion dollars in affordability programs and only a fraction of that spend reaches the patient.

We built our Benefit Patient Solution (BPS) to close that gap. It identifies disconnects in real time and makes the right calls on behalf of patients and providers, preventing GTN leakage of funds that are intended for patients.

The goal is a seamless experience for the patient, the pharmacist, and the provider.

Because you can be the best pharmacy practitioner in the world, but if the patient can’t afford their medicine, none of it matters.

Stephen Hom
Stephen Hom
Co-founder & COO

Stephen serves as Chief Operating Officer of RIS Rx, which he co-founded in 2020. Stephen manages all aspects of operations in RIS Rx's patient affordability and gross-to-net (GTN) revenue protection solutions for pharma manufacturers, routinely combining his deep knowledge as a frontline pharmacist with scalable tech-enabled workflows. He earned his PharmD from Loma Linda University. Read More